This inventor holds 2 USPTO granted patents. Top assignee: Genetics Institute, Inc.. Active years: 2000-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2005
Title: Inventor Ullrich S. Schwertschlag: Pioneering Innovations in Biomedical Treatments
Introduction
Ullrich S. Schwertschlag, an innovative inventor based in Beverly Farms, MA, is recognized for his significant contributions to the field of biomedical treatments. With two patents to his name, Schwertschlag focuses on the therapeutic applications of Interleukin-11, particularly in treating a range of debilitating conditions.
Latest Patents
Schwertschlag's latest patents include groundbreaking methods for utilizing IL-11 for treating mucositis and inflammatory bowel diseases. The first patent introduces topical formulations of Interleukin-11 designed to address various disorders such as Crohn's disease, ulcerative colitis, and mucositis in its many forms, including oral, gastrointestinal, nasal, and proctitis. His second patent also targets inflammatory bowel diseases, offering similar formulations and methods for treating associated conditions like psoriasis, aphthous ulcers, and even ocular diseases such as conjunctivitis and retinitis. These patents highlight his innovative approach to addressing complex health issues through targeted biomedical solutions.
Career Highlights
Schwertschlag's career is marked by his affiliation with Genetics Institute, Inc., where he actively contributes to research and development in the field of biotechnology. His commitment to understanding and treating inflammatory conditions has positioned him as a valuable asset to his team and the broader medical community.
Collaborations
Throughout his career, Schwertschlag has collaborated with notable colleagues, including Nick W. Warne and Camille L. Bedrosian. These partnerships have fostered an environment of innovation and have facilitated the development of effective solutions to pressing medical challenges.
Conclusion
Ullrich S. Schwertschlag's contributions to the field of biomedical treatment through his patents on Interleukin-11 underscore his role as an influential inventor. His work not only serves to enhance treatment options for those suffering from various diseases but also exemplifies the spirit of innovation within the medical research community. With ongoing efforts and collaborations, Schwertschlag continues to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile